跳至主要内容
临床试验/NCT07524023
NCT07524023进行中(未招募)不适用

Emotional-distress-based Integrated Care Programme in Patients With Stable COPD - A Feasibility Study (EmoD-2)

University of Zurich1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2026年3月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
15
试验地点
1
主要终点
Change in COPD-related emotional distress (CRED)

研究概览

简要总结

The investigators have developed a new counselling service that focuses on the emotional distress experienced by people living with chronic obstructive pulmonary disease (*COPD*). The new programme is led by an advanced practice nursing (*APN*) team. Other professionals are involved in the programme, such as medical staff and physiotherapists. The new counselling service lasts three months. Patients will receive ten counselling sessions with a specialized nurse. The overall objective of the study is to assess the feasibility of the newly developed emotional-distress-based integrated care programme.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a confirmed diagnosis of COPD (GOLD 1-4) and existing lung function in the past 12 months
  • Outpatient treatment on the pneumology clinic of the university hospital Zurich. Last consultation within the past 12 months

排除标准

  • Significant changes in symptoms over the past 3 months that exceeded the everyday fluctuations and required intensification of treatment (moderate, severe exacerbations or pneumonia) and no COPD-related hospitalisation in the past 3 months
  • Cognitive impairment (dementia, delirium)
  • Unstable psychiatric situation, i.e., current psychiatric treatment due to personality disorder, schizophrenia, drug use, suicidal tendencies. No exclusion for nicotine and alcohol abuse, anxiety, and depression
  • Not speaking or reading German
  • Intervention via telephone or video call not possible
  • Lung transplant (recipient or candidate)

研究组 & 干预措施

EmoD Intervention

Experimental

干预措施: EmoD Intervention (Other)

结局指标

主要结局

Change in COPD-related emotional distress (CRED)

时间窗: Quantitative data will be collected baseline, in the first month (Baseline measurement, week 0-4), and follow-up, three months after (week 14-17)]

Change in COPD-related emotional distress between baseline and month 3. COPD-related emotional distress will be assessed using the newly developed "COPD-Related Emotional Distress Questionnaire (CRED)", which was developed for CF and COPD patients (publication in progress; former name of the questionnaire: IRED-RESP). The questionnaire includes 36 items and assesses distress related to symptoms, treatment, restrictions in range of mobility and participation in social life, unpredictability of the disease and stigma, using a 5-point Likert scale. Higher scores mean more emotional distress (worse outcome).

次要结局

  • Reach: Total number of patients who take up the programme(Four months)
  • Reach: Percentage of patients who take part in at least one outpatient intervention(Four months)
  • Reach: Reasons for participating in the programme (facilitators and barriers)(Four months)
  • Reach: Reasons for ending (prematurely or on schedule) the programme (facilitators and barriers)(Four months)
  • Potential effectiveness: Change in depression(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in anxiety(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health-related quality of life (*QoL*)(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Patient satisfaction with programme(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Number of moderate exacerbations within 3 months(Study duration per patient is three months, with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second, measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Number of severe exacerbations within 3 months(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Rehospitalisation at day 90(Study duration per patient is three months, with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second, measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour smoking- current status(Study duration per patient is three months, with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second, measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour smoking - ex- smoker(Study duration per patient is three months, with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second, measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour smoking -smoker(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour nutrition - body weight(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour nutrition - body height(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour nutrition - BMI(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour nutrition - NRS(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour physical activity - C-PPAC(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour physical activity - Pulmonary rehabilitation(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour inhalation adherence(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour action plan(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Potential effectiveness: Change in health behaviour oxygen use(Study duration per patient is three months with two measurement points. Baseline measurements will be applied in the first month (week 0-4). Second measurement will take place in month four (week 14-17).)
  • Implementation: Percent of programme components carried out according to the intervention manual(Six months)
  • Implementation: Acceptability of the programme(Six months)
  • Implementation: Appropriateness of the programme(Six months)
  • Implementation: Feasibility of the programme(Six months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验